Women's health (London, England)

Womens Health (Lond) · ISSN (e) 1745-5065 · 196 papers in corpus
review 2016
doi:10.2217/whe.15.100 ·PMID:26695687

Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an…

review 2016
doi:10.2217/whe.15.81 ·PMID:26695831

Heavy menstrual bleeding (HMB) is a common gynecological complaint with multiple etiologies and diverse pathophysiological origins. This review discusses HMB with reference to the recently proposed PALM-COEIN classification system for abnor…

other 2016
doi:10.2217/whe.15.111 ·PMID:27189894

OBJECTIVE: Some ovarian malignancies may originate in the fallopian tube. The feasibility of ultrasonographically visualizing the fallopian tube is presented. METHODS: In total, 549 normal women participated in the fallopian tube visualiza…

other 2016
doi:10.2217/whe-2016-0006 ·PMID:26880048
case-report 2016
doi:10.2217/whe.16.2 ·PMID:27167412

UNLABELLED: Case presented at "Stump the Professors" 44th American Association of Gynecologic Laparoscopists Global Congress on Minimally Invasive Gynecology, NV, USA, 15-19 November 2015 BACKGROUND: Spontaneous torsion of the fallopian tub…

review 2016
doi:10.2217/whe.15.89 ·PMID:26693796

Uterine fibroids can cause abnormal uterine bleeding and their removal is beneficial in the treatment of heavy menstrual bleeding associated with fibroids for women who would like to preserve their uterus and fertility. Endoscopic (hysteros…

other 2016
doi:10.1177/1745505716655556 ·PMID:27638891
other 2016
doi:10.1177/1745505716653695 ·PMID:27638896

Several studies have demonstrated that the combination of hysteroscopy with endometrial biopsy is more accurate in differentiating endometrial polyps from endometrial hyperplasia and cancer. However, blind biopsy not always confirms hystero…

other 2016
doi:10.2217/whe-2016-0007 ·PMID:27282840
review 2016
doi:10.2217/whe.15.78 ·PMID:26756068

Uterine artery embolization (UAE) as a treatment option for fibroids was first reported by Ravina in 1995. Although rapidly adopted by enthusiasts, many were skeptical and its introduction varied widely across the globe. It was not until ra…

review 2015
doi:10.2217/whe.15.60 ·PMID:26315369

Adenomyosis is described as the benign invasion of endometrium into the myometrium, with endometrial glands and stroma surrounded by the hypertrophic and hyperplastic myometrium. It may affect 20% of female population and most widely seen a…

review 2015
doi:10.2217/whe.15.30 ·PMID:26450216

Chronic pelvic pain (CPP) is common in women of reproductive age and has a significant impact on quality of life, work efficiency and healthcare utilization. CPP can be a manifestation of many different, often multifactorial conditions, and…

review 2015
doi:10.2217/whe.15.55 ·PMID:26315050

Endometriosis is a common chronic disease mostly seen in young women. Endometriosis surgery may be considered as rather challenging in gynecology. In this article, we tried to emphasize on basic concepts of endometriosis surgery, the best s…

review 2015
doi:10.2217/whe.14.68 ·PMID:25581052

Suppression of estrogen production and reduction of menstrual blood flow are the mainstays of medical treatment of endometriosis-related pain and have been traditionally achieved by methods such as combined hormonal contraception, progestin…

review 2015
doi:10.2217/whe.15.59 ·PMID:26343168

Endometriosis is a common but an enigmatic disease in which endometrial glands and stroma are found outside the uterus. Worldwide, 80 million women are affected by the disease. It has generally been accepted as a problem of reproductive age…

review 2015
doi:10.2217/whe.15.53 ·PMID:26344663

Endometriosis is characterized by development of the endometrial tissue outside the uterus like ovary, pelvic peritoneum, pelvic organs, and affects 6-10% of reproductive-aged women. The prevalence of endometrioma is 17-44% of women with en…

review 2015
doi:10.2217/whe.14.57 ·PMID:25581054

Endometriosis is a complex gynecologic condition affecting 6-10% of reproductive aged women and is a major cause of chronic pain and infertility. Mechanisms of disease pathogenesis are poorly understood. Considerable evidence supports the e…

review 2015
doi:10.2217/whe.15.58 ·PMID:26315257

Endometriosis affects a significant proportion of teenagers. Published studies suggest that laparoscopically confirmed endometriosis could be found in over 60% of adolescent girls undergoing laparoscopic investigation for pain, in 75% of gi…

review 2015
doi:10.2217/whe.15.51 ·PMID:26314760

Endometriosis is defined as the presence of endometrial gland and stroma outside the uterine cavity. It is an estrogen-dependent disease and is associated with chronic pelvic pain, dysmenorrhea, dyspareunia and infertility. The treatment of…

review 2015
doi:10.2217/whe.14.74 ·PMID:25776287

Several clinical and epidemiological studies demonstrated an association between endometriosis and infertility. A role in the genesis of infertility may be played by endometriomas, which may interfere with ovulation or damage ovarian tissue…

review 2015
doi:10.2217/whe.15.49 ·PMID:26344549
other 2015
doi:10.2217/whe.15.61 ·PMID:26343282
review 2015
doi:10.2217/whe.15.41 ·PMID:26441051

Endometriosis is a heritable complex disorder that is influenced by multiple genetic and environmental factors. Identification of these genetic factors will aid a better understanding of the underlying biology of the disease. In this articl…

review 2015
doi:10.2217/whe.15.50 ·PMID:26395161

Endometriosis is an enigmatic disease affecting 10-15% of reproductive aged women and is encountered in 25-35% of women suffering from infertility. IVF is an effective tool to overcome endometriosis-associated infertility when expectant man…

review 2015
doi:10.2217/whe.15.57 ·PMID:26389731

Endometriosis is a condition that is characterized by the presence of endometrial tissue implants that are outside the uterine lining. It is presented in 10–15% of women in the reproductive age group, 2–5% of postmenopausal women, 25–30% of…